American Journal of Hematology
Aug 13, 2025, 05:23
Baseline Hemoglobin Predicts Outcomes in Acute VTE: Low Hb Linked to Higher Bleeding, Ischemia and Mortality Risk
Cardiovascular Diseases Research Institute posted on X:
”Baseline hemoglobin (Hb) predicts 90-day outcomes in acute venous thromboembolism (VTE): lower Hb links to higher risk of bleeding, ischemia, and death.
Personalizing anticoagulation by Hb may improve care.”
Read the full article here.
Article: Baseline Hemoglobin Values and Clinical Outcomes in Acute Venous Thromboembolism: Insights From the RIETE Registry
Authors: Carmine Siniscalchi, Pierpaolo Di Micco, Antonella Tufano, Maria Luisa Peris, Patricia López-Miguel, Alicia Alda-Lozano, Pilar Llamas, Diego Durán Barata, Yaser Jenab, Manuel Monreal, the RIETE Investigators
Stay updated on the latest scientific advances in the field of Hematology with Haemostasis Today.
Acute Venous Thromboembolism
Acute VTE
Alicia Alda-Lozano
Antonella Tufano
bleeding
Carmine Siniscalchi
Diego Durán Barata
Haemostasis Today
Hb
Health
Hematology
Hemoglobin
Hemostasis Today
Ischemia
Manuel Monreal
Maria Luisa Peris
Medicine
Mortality
Patricia López-Miguel
Personalizing anticoagulation
Pierpaolo Di Micco
Pilar Llamas
RIETE Investigators
venous thromboembolism
VTE
Yaser Jenab
-
Aug 13, 2025, 09:21VELORA Discover Study Now Enrolling: Advancing Care for Type 1 Von Willebrand Disease
-
Aug 13, 2025, 06:44Chokri Ben Lamine: Causes and Diagnostic Approach to PTT Prolongation
-
Aug 13, 2025, 05:41ISTH 2025 Recorded Sessions Now Available on ISTH Academy
-
Aug 13, 2025, 01:39Radoslaw Kaczmarek: Challenges Limiting Gene Therapy Use in Hemophilia
-
Aug 12, 2025, 20:03David McIntosh Urges WHO, the European Blood Alliance, the International Plasma and Fractionation Association to Stop Opposition to VRCD
-
Aug 13, 2025, 16:24Giuseppe Lippi on Laboratory Diagnostics for Immediate Management of Acute Bleeding
-
Aug 13, 2025, 06:13Pip Nicolson: Understanding VITT From COVID-19 Vaccines
-
Aug 13, 2025, 05:23Baseline Hemoglobin Predicts Outcomes in Acute VTE: Low Hb Linked to Higher Bleeding, Ischemia and Mortality Risk
-
Aug 13, 2025, 04:13Lindsey George on Gene Therapy Transforming Hemophilia Care
-
Aug 13, 2025, 02:26Case Report Alert: Basilar Artery Occlusion in IgA-APS
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Jul 26, 2025, 17:56HIPEITHO Trial Achieves Remarkable Enrollment Milestone Across 72 Sites in the US and Europe
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Jul 13, 2025, 16:05EMA and HMA Mark a Key Step with 1st AI Observatory Report
-
Aug 13, 2025, 15:50Will Parsons Honors National Leaders in Hematology: Drs. Fasipe, Powers and Tubman
-
Aug 13, 2025, 10:25Joshua Muia on His HTRS Leadership Role Impact
-
Aug 11, 2025, 05:16Andreas Calatzis: Any Information on Soviet Thrombelastographs?
-
Aug 9, 2025, 15:36NBCA: Blood Clot Survivor Runs 2025 NYC Marathon with Team Stop the Clot
-
Aug 8, 2025, 18:33Hemophilia Alliance during Tennessee Hemophilia and Bleeding Disorders Foundation Annual Meeting 2025
Aug 13, 2025, 10:25
Aug 13, 2025, 09:44
Aug 13, 2025, 07:58
Aug 13, 2025, 06:44
Aug 13, 2025, 06:13
Aug 13, 2025, 05:41
Aug 13, 2025, 04:13